Literature DB >> 17220694

Refractive hypotension in a patient with disulfiram-ethanol reaction.

Min-Po Ho1, Chia-Hung Yo, Chang-Ming Liu, Chun-Lin Chen, Chien-Chang Lee.   

Abstract

Disulfiram (Antabuse) is used for aversive treatment of alcohol dependence with good effects. Through inhibition of aldehyde dehydrogenase, disulfiram heightens serum aldehyde concentration after alcohol ingestion and causes aversive disulfiram-ethanol reaction. Typical symptoms of this reaction include flushing, nausea, dyspnea, tremor, and confusion, which are usually self-limiting. However, severe life-threatening arterial hypotension sometimes develops. We report here a patient with generalized flushing, tremor, and refractive hypotension after ingestion of alcohol 18 hours after disulfiram treatment. Initial volume resuscitation and dopamine infusion failed to restore the blood pressure. Noradrenaline was given and the blood pressure returned to normal range. This case illustrates the intensity of disulfiram-ethanol reaction and underscores the advantageous use of noradrenaline in patients in such a critical condition.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17220694     DOI: 10.1097/00000441-200701000-00007

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  3 in total

1.  Cephalosporin induced disulfiram-like reaction: a retrospective review of 78 cases.

Authors:  Shiyan Ren; Yuxia Cao; Xiuwei Zhang; Shichen Jiao; Songyi Qian; Peng Liu
Journal:  Int Surg       Date:  2014 Mar-Apr

2.  Recognition of a disulfiram ethanol reaction in the emergency department is not always straightforward.

Authors:  Kristof Segher; Liesbeth Huys; Tania Desmet; Evi Steen; Stefanie Chys; Walter Buylaert; Peter De Paepe
Journal:  PLoS One       Date:  2020-12-03       Impact factor: 3.240

3.  Can Lipoic Acid Attenuate Cardiovascular Disturbances Induced by Ethanol and Disulfiram Administration Separately or Jointly in Rats?

Authors:  Anna Bilska-Wilkosz; Magdalena Kotańska; Magdalena Górny; Barbara Filipek; Małgorzata Iciek
Journal:  Oxid Med Cell Longev       Date:  2019-11-22       Impact factor: 6.543

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.